10th Edition of World Congress on Infectious Diseases
June 25-27, 2026 | Barcelona, Spain
Antimicrobial Drug Resistance
Antimicrobial Drug Resistance, a pressing concern in contemporary healthcare, underscores the importance of judicious antimicrobial use. Over time, microorganisms adapt to the drugs designed to eliminate them, leading to a reduction in treatment efficacy. The consequences are severe, as common infections become harder to treat, increasing the risk of the spread of infectious diseases. Global efforts are underway to combat antimicrobial resistance through enhanced surveillance, research, and public awareness campaigns. Encouraging responsible antibiotic use, promoting vaccination, and implementing infection prevention measures are crucial strategies. Collaboration between healthcare professionals, researchers, policymakers, and the public is essential to curb the rise of antimicrobial resistance and safeguard the effectiveness of these vital drugs for future generations.
Ranjan Ramasamy
IDFISH Technology, United States
Saurabh Chattopadhyay
University of Kentucky College of Medicine, United States
Yazdan Mirzanejad
University of British Columbia, Canada
Michele Mishto
Francis Crick Institute, United Kingdom
Seki Masafumi
Saitama Medical University International Medical Center, Japan
Chukwuemeka Iloegbu
NYU/Emarin, United States
Stephanie Maltais
University of Montreal, CanadaSubmit your abstract Today
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain